First Trust Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-12,039
| Closed | -$636K | – | 2577 |
|
2024
Q3 | $636K | Sell |
12,039
-9,350
| -44% | -$494K | ﹤0.01% | 2115 |
|
2024
Q2 | $1.16M | Sell |
21,389
-16,560
| -44% | -$897K | ﹤0.01% | 1911 |
|
2024
Q1 | $2.66M | Buy |
+37,949
| New | +$2.66M | ﹤0.01% | 1610 |
|
2023
Q2 | – | Sell |
-58,292
| Closed | -$2.05M | – | 2369 |
|
2023
Q1 | $2.05M | Sell |
58,292
-50,019
| -46% | -$1.76M | ﹤0.01% | 1682 |
|
2022
Q4 | $4.96M | Buy |
108,311
+41,947
| +63% | +$1.92M | 0.01% | 1199 |
|
2022
Q3 | $3.22M | Buy |
66,364
+31,485
| +90% | +$1.53M | ﹤0.01% | 1417 |
|
2022
Q2 | $1.37M | Sell |
34,879
-32,123
| -48% | -$1.26M | ﹤0.01% | 1864 |
|
2022
Q1 | $2.47M | Sell |
67,002
-87,077
| -57% | -$3.2M | ﹤0.01% | 1698 |
|
2021
Q4 | $7.02M | Buy |
+154,079
| New | +$7.02M | 0.01% | 1207 |
|
2021
Q3 | – | Sell |
-75,858
| Closed | -$1.5M | – | 2539 |
|
2021
Q2 | $1.5M | Buy |
75,858
+26,570
| +54% | +$526K | ﹤0.01% | 1917 |
|
2021
Q1 | $1.15M | Buy |
49,288
+10,583
| +27% | +$246K | ﹤0.01% | 1944 |
|
2020
Q4 | $804K | Buy |
+38,705
| New | +$804K | ﹤0.01% | 1981 |
|